
News|Articles|October 1, 2008
Formulary Digital Edition October 2008
Rational approaches to the treatment of mixed dyslipidemia; Focus on eltrombopag; Drug Watch: Agents in late-stage development for the treatment of hepatitis B and C virus infections
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
Cancer survival fell and deaths rose during first two years of COVID-19
3
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
4
TrumpRx launches; some experts question its long-term value
5























